ArticleBioMed research international2022

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer.

Yu-Jeong Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.